Thermogelling composition for intranasal administration of active agents and methods of obtaining the same

MX2025003269APending Publication Date: 2026-10-02CENTRO DE INVESTIGACION Y ASISTENCIA EN TECNOLOGIA Y DISENO DEL ESTADO DE JALISCO A C +1
0 Cites 0 Cited by

Patent Information

Application Number
MX2025003269
Authority / Receiving Office
MX · MX
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-03-20
Publication Date
2026-10-02
Patent Text Reader

Abstract

The present invention provides a composition that favors the permeability of the nasal epithelium and allows the passage of therapeutic agents through the BBB into the CNS by an intranasal composition comprising functionalized chitosan, a cytoprotective agent and a gelling agent for intranasal administration of active agents, allows the incorporation of biological agents preserving the viability thereof, particularly of therapeutic cells, which gels at the body temperature of intranasal administration, a process for the manufacture thereof and its use in the prophylaxis or treatment of a disease of the central nervous system.
Need to check novelty before this filing date? Find Prior Art